info@synchemia.com | sales@synchemia.com 
9766925136 | 72 
Xanomeline
Xanomeline | CAS NO: 174656-58-7, Xanomeline is a muscarinic acetylcholine receptor agonist with a unique profile, primarily targeting M1 and M4 receptor subtypes. It has been investigated for several central nervous system (CNS) conditions, primarily because of its pro-cognitive and antipsychotic potential.
We are the Synchemia Research Chemical specializes in manufacturing and supplying of Xanomeline impurities that meet specific pharmacopeial standards (EP/BP/USP/IP) as well as process-related impurities Use: Treatment of schizophrenia symptoms, particularly positive symptoms (like hallucinations and delusions), as well as negative symptoms and cognitive impairment. Status: Under clinical development; xanomeline-trospium (a combination with the peripheral antagonist trospium to reduce side effects) has shown promise in Phase 3 trials.Buy Reliable and High-Purity Xanomeline Impurities, Delivered by Synchemia Research Chemicals.
Download catalogue
Pharmaceutical Reference Standards
| CAT No | SRC-X24081 |
| CAS No | 131986-45-3 |
| Mol.F. | C14H23N3OS |
| Mol.Wt. | 281.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-X24082 |
| CAS No | 174656-58-7 |
| Mol.F. | C14H23N3O2S |
| Mol.Wt. | 297.4 g/mol |
| INV STATUS | IN STOCK |
| CAT No | SRC-X24083 |
| CAS No | 2414049-88-8 |
| Mol.F. | C14H20N3O2S |
| Mol.Wt. | 294.4 g/mol |
| INV STATUS | IN STOCK |
| CAT No | SRC-X24084 |
| CAS No | 131986-28-2 |
| Mol.F. | C7H4ClN3S |
| Mol.Wt. | 197.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-X24085 |
| CAS No | 131987-69-4 |
| Mol.F. | C13H17N3OS |
| Mol.Wt. | 263.4 g/mol |
| INV STATUS | IN STOCK |
| CAT No | SRC-X24086 |
| CAS No | 131988-19-7 |
| Mol.F. | C14H20N3OS : I |
| Mol.Wt. | 278.4 : 126.9 g/mol |
| INV STATUS | IN STOCK |
| CAT No | SRC-X24087 |
| CAS No | 131988-63-1 |
| Mol.F. | C7H7N3 |
| Mol.Wt. | 133.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-X24088 |
| CAS No | NA |
| Mol.F. | C14H23N3O2S |
| Mol.Wt. | 297.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-X24089 |
| CAS No | NA |
| Mol.F. | C13H21N3OS |
| Mol.Wt. | 267.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-X24090 |
| CAS No | NA |
| Mol.F. | C14H21N3OS |
| Mol.Wt. | 279.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
.png)
| CAT No | SRC-X24091 |
| CAS No | NA |
| Mol.F. | C14H25N3OS |
| Mol.Wt. | 283.4 g/mol |
| INV STATUS | IN STOCK |
| CAT No | SRC-X24092 |
| CAS No | 17604-74-9 |
| Mol.F. | C7H6N2O |
| Mol.Wt. | 134.1 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
Let’s advance your research together.
Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.
